Denmark· DK-28106380119

Tivicay

A dolutegravir product containing dolutegravirnatrium, registered in Denmark by Viiv Healthcare BV. The same ATC class is registered in 13 of our 19 countries.

ATC J05AJ03

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedTivicayATCJ05AJ03REGISTER NO.DK-28106380119PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Dolutegravir is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AJ03 (dolutegravir), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 8 of them publish a price we can compare per daily dose

Dolutegravir · ATC J05AJ03

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dolutegravir costs, country by country.

Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Dolutegravir · price per daily dose (50 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$25.85
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Dolutegravirnatrium
Manufacturer
Viiv Healthcare BV
Country
Denmark (DK)
ATC code
J05AJ03
ATC class
Dolutegravir
Defined daily dose
50 mg, O
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28106380119

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

94 interactions on record for dolutegravir.

Graded by severity as the source publishes them — 42 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Dolutegravir · interactions on record

94 records

  • 42 severe
  • 3 moderate
  • 49 minor

Most severe, free to view

  • Magnesium carbonateA02AA01severe
  • Magnesium oxideA02AA02severe
  • Magnesium hydroxideA02AA04severe
  • Kombinationen von AluminiumsalzenA02AB10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d999cd33-55c2-492a-94bd-b86cd88503ca
GET /v1/drugs/d999cd33-55c2-492a-94bd-b86cd88503ca?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "dispergible tabletter",
  "source": "dkma",
  "strength": "5 mg",
  "auth_role": "MOD",
  "dk_drugid": "28106380119",
  "substance": "Dolutegravirnatrium",
  "auth_procedure": "Central",
  "in_medicinpriser": true,
  "registration_date_serial": "44207"
}

See everything about dolutegravir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.